What is ActX?
ActX is at the forefront of personalized medical care, specializing in the seamless integration of genetic data into Electronic Health Record (EHR) systems. The company provides healthcare providers with real-time genomic decision support, enhancing the efficacy and safety of prescriptions by considering individual genetic profiles. ActX's mission is to empower patients and clinicians with genetic insights for more informed medical decisions, offering customizable solutions for individuals, healthcare providers, and health systems.
How much funding has ActX raised?
ActX has raised a total of $5.9M across 4 funding rounds:
Private Equity
$1.9M
Private Equity
$750K
Private Equity
$3.1M
Debt
$150K
Private Equity (2013): $1.9M, investors not publicly disclosed
Private Equity (2014): $750K, investors not publicly disclosed
Private Equity (2016): $3.1M, investors not publicly disclosed
Debt (2020): $150K featuring PPP
Key Investors in ActX
PPP
Public-Private Partnership
What's next for ActX?
With its recent major strategic investment, ActX is poised for significant expansion and further development of its genomic decision support platform. This capital infusion is expected to accelerate the company's ability to integrate advanced genetic insights into mainstream healthcare, potentially driving broader adoption of precision medicine. The company's focus on enhancing patient care through genetic data positions it for continued growth in the evolving healthcare technology landscape.
See full ActX company page
